Kohvakka and colleagues further demonstrated that the ERG- and AR-regulated lncRNA EPCART (ERG-positive PC-associated androgen responsive transcript) is functionally relevant for prostate cancer, as knockout of EPCART reduces migration and proliferation of LNCaP cells. The gene discussed is AR; the disease is Familial prostate cancer.